IFNA1 and systemic lupus erythematosus: In the same manner, administration of siRNA-STAT1 to monocytes/macrophages using dendrimeric NPs as a delivery tool inhibits the IFN-mediated inflammation that occurs during systemic lupus erythematosus (SLE).